Anzeige
Mehr »
Sonntag, 29.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DPXX | ISIN: US48208B2034 | Ticker-Symbol:
NASDAQ
27.06.25 | 15:30
1,070 US-Dollar
-0,93 % -0,010
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
JUPITER NEUROSCIENCES INC Chart 1 Jahr
5-Tage-Chart
JUPITER NEUROSCIENCES INC 5-Tage-Chart

Aktuelle News zur JUPITER NEUROSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrJupiter Neurosciences to launch skin health supplement this fall1
MoJupiter Neurosciences, Inc.: Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia Brand Ambassador1
12.06.Pre-market Movers: Creative Global Technology, Liminatus Pharma, CureVac, Jupiter Neurosciences, Tonix Pharmaceuticals472BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.05 A.M. ET).In the Green Creative Global Technology Holdings Limited (CGTL)...
► Artikel lesen
09.06.Jupiter Neurosciences launches Nugevia longevity products2
09.06.Jupiter Neurosciences, Inc.: Jupiter Neurosciences Launches Nugevia: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science1.215First consumer products roll out in Q3 2025, creating near-term revenue potential and marking a new chapter in Jupiter's evolution Jupiter, Florida, June 09, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences...
► Artikel lesen
15.05.JUPITER NEUROSCIENCES, INC. - 10-Q, Quarterly Report3
21.04.JUPITER NEUROSCIENCES, INC. - 8-K, Current Report5
08.04.Jupiter Neurosciences zielt auf Parkinson- und Langlebigkeitsmärkte ab5
JUPITER NEUROSCIENCES Aktie jetzt für 0€ handeln
08.04.Jupiter Neurosciences targets Parkinson's and longevity markets1
28.03.JUPITER NEUROSCIENCES, INC. - 10-K, Annual Report3
25.03.JUPITER NEUROSCIENCES, INC. - 8-K, Current Report2
07.03.RedChip Companies, Inc.: Alliance Entertainment and Jupiter Neurosciences Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV411ORLANDO, FL / ACCESS Newswire / March 7, 2025 / RedChip Companies will air interviews with Alliance Entertainment Holding Corp. (Nasdaq:AENT) and Jupiter Neurosciences, Inc. (Nasdaq:JUNS) on the RedChip...
► Artikel lesen
04.02.Jupiter Neurosciences, Inc.: Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones3
03.02.Jupiter Neurosciences Partners with Catalent to Produce JOTROL Softgels for Upcoming Clinical Trial4
30.01.Jupiter Neurosciences partners with Zina for Parkinson's trial4
30.01.Jupiter Neurosciences geht Partnerschaft mit Zina für Parkinson-Studie ein2
30.01.Jupiter Neurosciences, Inc.: Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial254Jupiter, Florida, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL, a patented resveratrol-based...
► Artikel lesen
24.01.Pre-market Movers: Allurion Technologies, Nvni Group, Dogwood Therapeutics, Jupiter Neurosciences, Ctrl Group1.122BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.15 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 297%...
► Artikel lesen
04.12.24Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering315Jupiter, Florida, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the "Company" or "Jupiter Neurosciences"), a clinical stage pharmaceutical company advancing a pipeline...
► Artikel lesen
03.12.24Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq266Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq: JUNS) (the "Company" or "Jupiter Neurosciences"), a clinical stage pharmaceutical company advancing a pipeline...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1